JUN-1111
Product Specifications
UNSPSC Description
JUN-1111 is an irreversible and selective Cdc25 phosphatase inhibitor with IC50 values of 0.38, 1.8, 0.66, 28, 37 µM for Cdc25A, Cdc25B, Cdc25C, VHR, PTP1B, respectively. JUN-1111 induces cell cycle arrest at G1 and G2/M phases. JUN-1111 decreases the expression of phosphoCdk1[1][2].
Target Antigen
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/jun-1111.html
Purity
98.57
Solubility
DMSO : 100 mg/mL (ultrasonic;heat to 80°C)
Smiles
O=C(C=C1NCCN2CCOCC2)C3=C(N=CC=C3)C1=O
Molecular Weight
287.31
References & Citations
[1]Brisson M, et al. Redox regulation of Cdc25B by cell-active quinolinediones. Mol Pharmacol. 2005 Dec;68(6):1810-20. |[2]Vogt A, et al. A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells. Mol Cancer Ther. 2008 Feb;7(2):330-40.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-118529/JUN-1111-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-118529/JUN-1111-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
874351-38-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![8-[ (4-Amino) butyl]-amino-ATP-MANT](https://cdn.genprice.uk/genprice/genprice4.png)
